Character Biosciences is a San Francisco-based precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology.

We’re leveraging human genetics to understand what drives disease progression so we can discover and develop targeted therapies to more effectively treat patients. Character Bio integrates genomics with longitudinal clinical data, imaging, and AI-enabled biomarker quantification for thousands of patients affected by AMD and POAG, leading us to unprecedented insights into the genetic drivers of disease progression.

Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients. We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.

CTX203 | Character Biosciences

Product description

Character Biosciences San Francisco, United States (US)

Price: N/A

Character Biosciences
San Francisco, United States (US)